ASX:RHT

Resonance Health Stock Forecast, Price & News

Add
Compare
Today's Range N/A
50-Day Range N/A
52-Week Range N/A
Volume2.57 million shs
Average VolumeN/A
Market CapitalizationN/A
P/E RatioN/A
Dividend YieldN/A
BetaN/A

Receive RHT News and Ratings via Email

Sign-up to receive the latest news and ratings for Resonance Health and its competitors with MarketBeat's FREE daily newsletter.


About Resonance Health

Resonance Health Limited, a healthcare company, develops and delivers non-invasive medical imaging software and services worldwide. Its flagship products include FerriScan, a non-invasive liver diagnostic technology used for the measurement of liver iron concentration; and FerriSmart, an automated software medical device to manage patients with iron overload disorders, such as thalassemia, sickle cell disease, hereditary haemochromatosis, anaemias, and cancers. The company also offers Cardiac T2, a dual analysis service with FerriScan to provide information regarding body iron stores; HepaFat-Scan, a magnetic resonance imaging (MRI) based tool for the measurement of volumetric liver fat fraction; HepaFat-AI, an artificial intelligence software tool, which is used for the automated assessment of liver fat from MRI data; and Bone Marrow R2-MRI for the assessment of iron levels in the bone marrow. It also provides imaging core laboratory and support services for clinical trials. The company serves clinicians for the diagnosis and management of human diseases; researchers; and pharmaceutical companies for their clinical trials. Resonance Health Limited was incorporated in 1987 and is headquartered in Burswood, Australia.

Headlines

See More Headlines

Industry, Sector and Symbol

Sales & Book Value

Profitability

Debt

Price-To-Earnings

Miscellaneous


MarketRank

Overall MarketRank

1.19 out of 5 stars

Analyst Opinion: 0.0Community Rank: 4.3Dividend Strength: 0.0Insider Behavior: 1.7Valuation: 0.0 5 -4 -3 -2 -1 -
speech bubbles
speech bubbles











Resonance Health (ASX:RHT) Frequently Asked Questions

What stocks does MarketBeat like better than Resonance Health?

Wall Street analysts have given Resonance Health a "N/A" rating, but there may be better buying opportunities in the stock market. Some of MarketBeat's past winning trading ideas have resulted in 5-15% weekly gains. MarketBeat just released five new stock ideas, but Resonance Health wasn't one of them. MarketBeat thinks these five companies may be even better buys.
View MarketBeat's top stock picks here.

Who are Resonance Health's key executives?

Resonance Health's management team includes the following people:
  • Ms. Alison Laws, Chief Exec. Officer
  • Mr. Mitchell M. Wells B.Com., L.L.B., LLB, B.Comm, Exec. Director (Age 46, Pay $130k)
  • Mr. Nick Allan, CFO & Company Sec.
  • Chat Tondut, Communications Mang.
  • Ms. Celine Royet, Quality Assurance & Regulatory Affairs Mang.
  • Dr. Jason Loveridge B.Sc., B.Sc, Ph.D., FRSM, Corp. Advisor

Who are some of Resonance Health's key competitors?

What other stocks do shareholders of Resonance Health own?

What is Resonance Health's stock symbol?

Resonance Health trades on the ASX under the ticker symbol "RHT."

How much money does Resonance Health make?

Resonance Health has a market capitalization of $0.00 and generates $3.83 million in revenue each year.

What is Resonance Health's official website?

The official website for Resonance Health is www.resonancehealth.com.

How can I contact Resonance Health?

The company can be reached via phone at 61 8 9286 5300.


This page was last updated on 8/2/2021 by MarketBeat.com Staff
MarketBeat - Stock Market News and Research Tools logo

MarketBeat empowers individual investors to make better trading decisions by providing real-time financial data and objective market analysis. Whether you’re looking for analyst ratings, corporate buybacks, dividends, earnings, economic reports, financials, insider trades, IPOs, SEC filings or stock splits, MarketBeat has the objective information you need to analyze any stock. Learn more about MarketBeat.

MarketBeat is accredited by the Better Business Bureau

© American Consumer News, LLC dba MarketBeat® 2010-2021. All rights reserved.
326 E 8th St #105, Sioux Falls, SD 57103 | U.S. Based Support Team at [email protected] | (844) 978-6257
MarketBeat does not provide personalized financial advice and does not issue recommendations or offers to buy stock or sell any security.

Our Accessibility Statement | Terms of Service | Do Not Sell My Information

© 2021 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions. Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. To see all exchange delays and terms of use please see disclaimer. Fundamental company data provided by Zacks Investment Research.